74 related articles for article (PubMed ID: 16051634)
1. Inhibition of estradiol-induced mammary proliferation by dibenzoylmethane through the E2-ER-ERE-dependent pathway.
Lin CC; Tsai YL; Huang MT; Lu YP; Ho CT; Tseng SF; Teng SC
Carcinogenesis; 2006 Jan; 27(1):131-6. PubMed ID: 16051634
[TBL] [Abstract][Full Text] [Related]
2. Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation.
Kyprianou N; English HF; Davidson NE; Isaacs JT
Cancer Res; 1991 Jan; 51(1):162-6. PubMed ID: 1899037
[TBL] [Abstract][Full Text] [Related]
3. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling.
Jiang J; Slivova V; Sliva D
Int J Oncol; 2006 Sep; 29(3):695-703. PubMed ID: 16865287
[TBL] [Abstract][Full Text] [Related]
4. Estrogen dependent regulation of estrogen receptor gene expression in normal mammary gland and its relationship to estrogenic sensitivity.
Shyamala G; Schneider W; Guiot MC
Receptor; 1992; 2(2):121-8. PubMed ID: 1472945
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic studies on the inhibitory action of dietary dibenzoylmethane, a beta-diketone analogue of curcumin, on 7,12-dimethylbenz[a]anthracene-induced mammary tumorigenesis.
Lin CC; Ho CT; Huang MT
Proc Natl Sci Counc Repub China B; 2001 Jul; 25(3):158-65. PubMed ID: 11480771
[TBL] [Abstract][Full Text] [Related]
6. Antiestrogenic effect of 20S-protopanaxadiol and its synergy with tamoxifen on breast cancer cells.
Yu Y; Zhou Q; Hang Y; Bu X; Jia W
Cancer; 2007 Jun; 109(11):2374-82. PubMed ID: 17464948
[TBL] [Abstract][Full Text] [Related]
7. Inhibition by dietary dibenzoylmethane of mammary gland proliferation, formation of DMBA-DNA adducts in mammary glands, and mammary tumorigenesis in Sencar mice.
Lin CC; Lu YP; Lou YR; Ho CT; Newmark HH; MacDonald C; Singletary KW; Huang MT
Cancer Lett; 2001 Jul; 168(2):125-32. PubMed ID: 11403916
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells.
Lee YR; Park J; Yu HN; Kim JS; Youn HJ; Jung SH
Biochem Biophys Res Commun; 2005 Nov; 336(4):1221-6. PubMed ID: 16169518
[TBL] [Abstract][Full Text] [Related]
9. Modulation by phenylacetate of early estrogen-mediated events in MCF-7 breast cancer cells.
Liu J; Li J; Sidell N
Cancer Chemother Pharmacol; 2007 Feb; 59(2):217-25. PubMed ID: 16738884
[TBL] [Abstract][Full Text] [Related]
10. Estrogen-receptor-dependent regulation of telomerase activity in human endometrial cancer cell lines.
Boggess JF; Zhou C; Bae-Jump VL; Gehrig PA; Whang YE
Gynecol Oncol; 2006 Nov; 103(2):417-24. PubMed ID: 16690106
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of hTERT expression plays an important role in 15-deoxy-Delta12,14-prostaglandin J2-induced apoptosis in cancer cells.
Moriai M; Tsuji N; Kobayashi D; Kuribayashi K; Watanabe N
Int J Oncol; 2009 May; 34(5):1363-72. PubMed ID: 19360348
[TBL] [Abstract][Full Text] [Related]
12. Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells.
Girgert R; Hanf V; Emons G; Gründker C
J Pineal Res; 2009 Aug; 47(1):23-31. PubMed ID: 19522736
[TBL] [Abstract][Full Text] [Related]
13. RNAi-hTERT inhibition hepatocellular carcinoma cell proliferation via decreasing telomerase activity.
Zhang PH; Zou L; Tu ZG
J Surg Res; 2006 Mar; 131(1):143-9. PubMed ID: 16298398
[TBL] [Abstract][Full Text] [Related]
14. Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen.
Chen J; Power KA; Mann J; Cheng A; Thompson LU
Exp Biol Med (Maywood); 2007 Sep; 232(8):1071-80. PubMed ID: 17720953
[TBL] [Abstract][Full Text] [Related]
15. Lycopene and other carotenoids inhibit estrogenic activity of 17beta-estradiol and genistein in cancer cells.
Hirsch K; Atzmon A; Danilenko M; Levy J; Sharoni Y
Breast Cancer Res Treat; 2007 Aug; 104(2):221-30. PubMed ID: 17051425
[TBL] [Abstract][Full Text] [Related]
16. Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models.
Bhat KP; Lantvit D; Christov K; Mehta RG; Moon RC; Pezzuto JM
Cancer Res; 2001 Oct; 61(20):7456-63. PubMed ID: 11606380
[TBL] [Abstract][Full Text] [Related]
17. A possible regulatory role of 17beta-estradiol and tamoxifen on glyoxalase I and glyoxalase II genes expression in MCF7 and BT20 human breast cancer cells.
Rulli A; Antognelli C; Prezzi E; Baldracchini F; Piva F; Giovannini E; Talesa V
Breast Cancer Res Treat; 2006 Mar; 96(2):187-96. PubMed ID: 16319983
[TBL] [Abstract][Full Text] [Related]
18. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP
Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191
[TBL] [Abstract][Full Text] [Related]
19. Anti-estrogenic mechanism of unliganded progesterone receptor isoform B in breast cancer cells.
Zheng ZY; Zheng SM; Bay BH; Aw SE; C-L Lin V
Breast Cancer Res Treat; 2008 Jul; 110(1):111-25. PubMed ID: 17687644
[TBL] [Abstract][Full Text] [Related]
20. Genistein stimulates growth of human breast cancer cells in a novel, postmenopausal animal model, with low plasma estradiol concentrations.
Ju YH; Allred KF; Allred CD; Helferich WG
Carcinogenesis; 2006 Jun; 27(6):1292-9. PubMed ID: 16537557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
